Insights On Drug Discovery

31. Elevating Purity: Racemizing Pharmaceutical Products In Flow Microreactors 6/18/2025

    Discover how our process development team resolved a racemization challenge by delivering a biologically active racemic mixture while maintaining compound purity.

32. Experimental CCI — Induced Neuropathic Pain Model 6/18/2025

    Advance neuropathic pain research and therapeutic development with the Chronic Constriction Injury (CCI)-induced neuropathic pain model to uncover mechanisms and evaluate promising candidates.

33. Column Head Loading In SFC: A Novel Injection Technique For Polar Heterocycles, Oligopeptides 6/13/2025

    By improving sample loading uniformity and reducing solubility-related artifacts, see how a multiple-injection approach enhances the practicality and effectiveness of SFC for difficult-to-purify substances.

34. Leveraging Surface Plasmon Resonance For Characterizing Ternary Complexes 6/13/2025

    Uncover how Surface Plasmon Resonance (SPR) can be used to gain real-time, label-free insights into PROTAC binding kinetics and ternary complex formation.

35. Preclinical Evaluation Of Vaccines And Antivirals In RSV Challenge Rodent Models 6/10/2025

    Here, we present multiple case studies utilizing clinically relevant mouse and rat models to evaluate key characteristics of potential RSV therapeutics.

36. Preclinical Evaluation Of New Antifibrotics In NASH-Induced Fibrosis Models 6/10/2025

    Accelerate the development of antifibrotic therapies through our clinically relevant models, deep scientific expertise, and proven preclinical capabilities in this area of unmet medical need.

37. Preclinical Evaluation Of Antifibrotics In COVID-Induced Fibrosis Model 6/10/2025

    Advancing the development of effective antifibrotic therapies requires urgent investment in clinically relevant, IND-enabling preclinical models to address the growing burden of fibrotic diseases.

38. Preclinical Evaluation Of Vaccines And Antivirals In RSV Challenge SCID Mouse Models 6/10/2025

    Advance your RSV therapeutic pipeline with trusted, IND-enabling preclinical services that deliver clinically relevant data through optimized study designs and validated rodent models.

39. Preclinical Evaluation Of RSV Vaccines And Antivirals In BALB/c Mice 6/10/2025

    Accelerate your RSV therapeutic development with clinically relevant preclinical models and expert IND-enabling services that deliver the data needed to advance confidently toward clinical trials.

40. You Need 'Brutal Honesty' When Outsourcing 5/29/2025

    Our Outsourced Pharma Live speakers were adamant: You need a clear and honest assessment of what both the sponsor and CDMO need and bring to the relationship.